3rd Quarter - Report
AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY for AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY
Income
—
Expenses
$30,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
CARA, role of pharmacist in health systems working to reduce opioid abuse
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM GEORGE LANG | — |
Labor Issues/Antitrust/Workplace LBR
DOL overtime rule HJR 95, impact on biomedical research
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM GEORGE LANG | — |
Budget/Appropriations BUD
Budget caps and ending sequestration FY17 appropriation levels for federal public health agencies Funding for Zika virus threat Defense/VA approps Opioid abuse CARA
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM GEORGE LANG | — |
Medicare/Medicaid MMM
HR 592 S 314 FY17 funding for federal public health agencies
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM GEORGE LANG | Senior Policy Advisor |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.